EP4073263A4 - Verfahren zur stabilen komplexbildung und entsprechende kits - Google Patents

Verfahren zur stabilen komplexbildung und entsprechende kits Download PDF

Info

Publication number
EP4073263A4
EP4073263A4 EP21737980.9A EP21737980A EP4073263A4 EP 4073263 A4 EP4073263 A4 EP 4073263A4 EP 21737980 A EP21737980 A EP 21737980A EP 4073263 A4 EP4073263 A4 EP 4073263A4
Authority
EP
European Patent Office
Prior art keywords
methods
complex formation
stable complex
related kits
kits
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21737980.9A
Other languages
English (en)
French (fr)
Other versions
EP4073263A1 (de
Inventor
Kevin L. GUNDERSON
Norihito MURANAKA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Encodia Inc
Original Assignee
Encodia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Encodia Inc filed Critical Encodia Inc
Priority claimed from PCT/US2021/012224 external-priority patent/WO2021141924A1/en
Publication of EP4073263A1 publication Critical patent/EP4073263A1/de
Publication of EP4073263A4 publication Critical patent/EP4073263A4/de
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B20/00—Methods specially adapted for identifying library members
    • C40B20/04—Identifying library members by means of a tag, label, or other readable or detectable entity associated with the library members, e.g. decoding processes
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B70/00—Tags or labels specially adapted for combinatorial chemistry or libraries, e.g. fluorescent tags or bar codes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP21737980.9A 2020-01-07 2021-01-05 Verfahren zur stabilen komplexbildung und entsprechende kits Pending EP4073263A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062958176P 2020-01-07 2020-01-07
PCT/US2021/012224 WO2021141924A1 (en) 2020-01-07 2021-01-05 Methods for stable complex formation and related kits

Publications (2)

Publication Number Publication Date
EP4073263A1 EP4073263A1 (de) 2022-10-19
EP4073263A4 true EP4073263A4 (de) 2023-11-08

Family

ID=76655264

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21737980.9A Pending EP4073263A4 (de) 2020-01-07 2021-01-05 Verfahren zur stabilen komplexbildung und entsprechende kits

Country Status (2)

Country Link
US (1) US11169157B2 (de)
EP (1) EP4073263A4 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023086847A1 (en) 2021-11-10 2023-05-19 Encodia, Inc. Methods for barcoding macromolecules in individual cells
US20230203562A1 (en) 2021-12-28 2023-06-29 Encodia, Inc. High-throughput serotyping and antibody profiling assays

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2264271T3 (es) 1998-11-06 2006-12-16 Mitsubishi Kagaku Iatron, Inc. Complejos novedosos que contienen avidina reticulada, procedimiento de preparacion y procedimiento analitico de utilizacion de los mismos.
CZ20013399A3 (cs) 1999-03-23 2002-01-16 Biovation Limited Způsob izolace proteinů a analýzy proteinů, zejména hmotnostní analýzou
DK1670939T3 (da) 2003-09-18 2010-03-01 Nuevolution As Fremgangsmåde til opnåelse af strukturel information om et kodet molekyle og fremgangsmåde til udvælgelse af forbindelser
US9574189B2 (en) 2005-12-01 2017-02-21 Nuevolution A/S Enzymatic encoding methods for efficient synthesis of large libraries
US8642744B2 (en) 2010-10-28 2014-02-04 Agilent Technologies, Inc. Crosslinking reagent for analysis of protein-protein interaction
WO2016164530A1 (en) 2015-04-07 2016-10-13 University Of Maryland, College Park Compositions and methods for high throughput protein sequencing
US10870872B2 (en) 2016-04-04 2020-12-22 President And Fellows Of Harvard College Enzymatic nucleic acid synthesis
KR20230047506A (ko) * 2016-05-02 2023-04-07 엔코디아, 인코포레이티드 암호화 핵산을 사용한 거대분자 분석
WO2019089846A1 (en) 2017-10-31 2019-05-09 Encodia, Inc. Methods and compositions for polypeptide analysis
CA3081441C (en) 2017-10-31 2023-08-29 Encodia, Inc. Kits for analysis using nucleic acid encoding and/or label
EP3704246A4 (de) 2017-10-31 2021-08-11 Encodia, Inc. Verfahren und kits unter verwendung von nukleinsäurecodierung und/oder -markierung
CA3086915A1 (en) 2017-12-29 2019-07-04 Sujal M. Patel Decoding approaches for protein identification

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
XING SHUPING ET AL: "Techniques for the Analysis of Protein-Protein Interactions in Vivo", COMPREHENSIVE SEQUENCE ANALYSIS OF 24,783 BARLEY FULL-LENGTH CDNAS DERIVED FROM 12 CLONE LIBRARIES,, vol. 171, no. 2, 1 June 2016 (2016-06-01), pages 727 - 758, XP002761334, ISSN: 1532-2548, [retrieved on 20160425], DOI: 10.?1104/?PP.?16.?00470 *

Also Published As

Publication number Publication date
US20210208150A1 (en) 2021-07-08
EP4073263A1 (de) 2022-10-19
US11169157B2 (en) 2021-11-09

Similar Documents

Publication Publication Date Title
EP4038178A4 (de) Nährzusammensetzungen und verfahren, kits und zellzusammensetzungen zum produzieren derselben
EP3880799A4 (de) Mikrobielle zellen und verfahren zur herstellung von cannabinoiden
EP3963070A4 (de) Verfahren zur herstellung von analyten und zugehörige kits
EP3857539A4 (de) Instrument und verfahren zur echtzeit-musikerzeugung
EP4031607A4 (de) Enthüllbare substrate und verfahren zu deren herstellung und verwendung
EP3854819A4 (de) Nanocellulose und verfahren zur herstellung davon
EP4073263A4 (de) Verfahren zur stabilen komplexbildung und entsprechende kits
EP3973299A4 (de) Verfahren und zugehörige kits zur räumlichen analyse
EP3999066A4 (de) Zusammensetzungen und kits für omeprazol-suspension
EP3925954A4 (de) Fluorlacton und verfahren zur herstellung davon
EP4029949A4 (de) Kit und verfahren
EP4026855A4 (de) Zusammensetzung und herstellungsverfahren dafür
EP3938514A4 (de) Verbindungen und verfahren zur verringerung der kcnt1-expression
EP3922992A4 (de) Kit zur messung eines analyten und verfahren zur bestimmung eines analyten
EP3980068A4 (de) Zellkulturverfahren und zusammensetzungen zur produktion von antikörpern
EP4022041A4 (de) Nef-haltige t-zellen und verfahren zum produzieren davon
AU2020285524A1 (en) Methods and user interfaces for sharing audio
EP4071135A4 (de) Etelcalcetid-zwischenprodukt und verfahren zum synthetisieren von etelcalcetid
EP3849557A4 (de) Kits und verfahren zur behandlung von krebserkrankungen
AU2022298331A9 (en) Methods
EP3630684A4 (de) Sequestriermittel, kits dafür und verfahren zur verwendung von sequestriermitteln und kits dafür
EP4028058A4 (de) Zusammensetzungen und verfahren zur herstellung und verwendung von multispezifischen antikörpern
EP4025701A4 (de) Kits und verfahren zur prüfung des lungenkrebsrisikos
EP3911756A4 (de) Screening-verfahren und -kits für kolorektales neoplasma
GB202102391D0 (en) Methods and kits

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220712

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20231010

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/543 20060101ALI20231004BHEP

Ipc: C40B 70/00 20060101ALI20231004BHEP

Ipc: C40B 20/04 20060101ALI20231004BHEP

Ipc: C12Q 1/6869 20180101ALI20231004BHEP

Ipc: C12Q 1/6811 20180101ALI20231004BHEP

Ipc: C12Q 1/68 20180101AFI20231004BHEP